EMA Medicine safety communications
Voxzogo: change in dosing recommendation
Published by European Medicines Agency: · Ref. EMEA/H/C/005475/II/0007
Summary
Change in dosing recommendation
Medicine
Voxzogo
- Category
- Medicine safety communications
- Product type
- Human medicine
- Active substance(s): vosoritide
- Therapeutic area: Achondroplasia
- ATC code: M05BX
Measures and alternatives
- Regulatory outcome: Variation
Source: EMA — medicine safety communications — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗